DR. KARRY K WHITTEN, DDS
Dentist at Nicholas St, Omaha, NE
License number
Nebraska 6138
Category
Dentist
Type
Dentist
Address
Address
10020 Nicholas St STE 200, Omaha, NE 68114
Phone
(402) 392-2880
(402) 392-0729 (Fax)
(402) 392-0729 (Fax)
Organization information
See more information about KARRY K WHITTEN at bizstanding.comPiperis Interventional - Karry K Whitten DDS
1111 N 102 Ct STE 200, Omaha, NE 68114
Categories:
Dentists
Phone:
(402) 991-6559 (Phone)
Products:
Substance Abuse
Payment options:
American Express, Visa
Certifications:
American Board of Anesthesiology, Board Certified
Additional:
Restoring Wellness, Call for Appointment
Professional information
Associate Dentist At Nebraska Institute Of Cosmetic Dentistry
Location:
Greater Omaha Area
Industry:
Cosmetics
Experience:
Nebraska Institute of Cosmetic Dentistry (Cosmetics industry): associate dentist, (-)
Dr. Karry K Whitten, Omaha NE - DDS (Doctor of Dental Surgery)
Specialties:
Dentistry
Address:
1111 N 102Nd Ct STE 214, Omaha 68114
(402) 397-9330 (Phone)
(402) 397-9330 (Phone)
Languages:
English
Therapeutic Composition To Treat Lesions Caused By Herpes Simplex Virus
US Patent:
2012007, Mar 22, 2012
Filed:
May 26, 2011
Appl. No.:
13/116112
Inventors:
Karry Whitten - Omaha NE, US
International Classification:
A61K 31/522, A61P 31/22
US Classification:
51426332
Abstract:
The present invention is generally directed toward therapeutic compositions for treating infections caused by Herpes Simplex Virus (“HSV”). The therapeutic compositions meet a long felt need in the art of providing a treatment for lesions that result from HSV that drastically reduce the duration of a cold sore when vesicles have already appeared and a treatment that will prevent the outbreak of a lesion and formation of vesicles when applied in the prodromal stage. The therapeutic compound comprises a mixture of Acyclovir (“ACV”), Penciclovir (“PCV”), and dimethyl sulfoxide (“DMSO”). The therapeutic compositions of the present invention include multiple formulations of the three active ingredients and may also include inactive ingredients and/or additional active ingredients.
Therapeutic Composition To Treat Lesions Caused By Herpes Simplex Virus
US Patent:
2011006, Mar 17, 2011
Filed:
Sep 17, 2010
Appl. No.:
12/884698
Inventors:
Karry Whitten - Omaha NE, US
International Classification:
A61K 31/7004, A61P 31/22
US Classification:
514 23
Abstract:
The present invention is generally directed toward therapeutic compositions for treating infections caused by Herpes Simplex Virus (“HSV”). The therapeutic compositions meet a long felt need in the art of providing a treatment for lesions that result from HSV that drastically reduce the duration of a cold sore when vesicles have already appeared and a treatment that will prevent the outbreak of a lesion and formation of vesicles when applied in the prodormal stage. The therapeutic compound comprises a mixture of Acyclovir (“ACV”), Penciclovir (“PCV”), and 2-Deoxy-D-Glucose (“2-DDG”). The therapeutic compositions of the present invention include multiple formulations of the three active ingredients and may also include inactive ingredients.